Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions

Abstract

BackgroundVitiligo is a common skin disorder, characterized by progressive skin de-pigmentation due to the loss of cutaneous melanocytes. The exact cause of melanocyte loss remains unclear, but a large number of observations have pointed to the important role of cellular immunity in vitiligo pathogenesis.Methodology/Principal FindingsIn this study, we characterized T cell and inflammation-related dermal dendritic cell (DC) subsets in pigmented non-lesional, leading edge and depigmented lesional vitiligo skin. By immunohistochemistry staining, we observed enhanced populations of CD11c+ myeloid dermal DCs and CD207+ Langerhans cells in leading edge vitiligo biopsies. DC-LAMP+ and CD1c+ sub-populations of dermal DCs expanded significantly in leading edge and lesional vitiligo skin. We also detected elevated tissue mRNA levels of IL-17A in leading edge skin biopsies of vitiligo patients, as well as IL-17A positive T cells by immunohistochemistry and immunofluorescence. Langerhans cells with activated inflammasomes were also noted in lesional vitiligo skin, along with increased IL-1ß mRNA, which suggest the potential of Langerhans cells to drive Th17 activation in vitiligo.Conclusions/SignificanceThese studies provided direct tissue evidence that implicates active Th17 cells in vitiligo skin lesions. We characterized new cellular immune elements, in the active margins of vitiligo lesions (e.g. populations of epidermal and dermal dendritic cells subsets), which could potentially drive the inflammatory responses.

Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells

“…In SLE, these cells induce Ig class switching to IgG and increase Ig secretion in CD1c+ B cells (24). Conversely, CD1c high myeloid dendritic cells (CD1c+mDC) infiltrate inflamed tissues in different autoimmune conditions, including, for example, rheumatoid arthritis (RA), vitiligo, or autoimmune thyroiditis (23,25,26). In RA, these CD1c+mDC induce proliferation and cytokine secretion of autologous CD4+ T cells (27).…”

DermaGene and VitmiRS: a comprehensive systems analysis of genetic dermatological disorders

“…LTA, on the other hand, is involved in the follicular dendritic cells development and has been observed to induce signals leading to lymphoid neo-organogenesis driving the inflammatory responses in autoimmune diseases like rheumatoid arthritis (Takemura et al 2001). This suggests that etanercept may suppress lymphoid neo-organogenesis and reduce the proliferation of mature dendritic cells in vitiligo lesions (Wang et al 2011). The other drug, carfilzomib, is a tetrapeptide epoxyketone-based proteasome inhibitor that targets PSMB9 and PSMB8.…”

Treatment of Non-Segmental Vitiligo with Narrowband UVB Phototherapy (311 Nm): Clinical Efficacy and Mechanisms of Action

“…Immune responses in areas of vitiligo involve a complex interaction of melanocytes, keratinocytes, and lymphocytes. Skin dendritic cells which are responsible for recognizing and binding a foreign antigen and initiation of immune responses have significant importance in vitiligo pathogenesis as well [8,9].…”